ORKA

Oruka Therapeutics (ORKA)

Oruka Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ORKA

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/19	21:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/12/19	21:00	GlobeNewswire Inc.	Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/12/18	21:00	GlobeNewswire Inc.	Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/27	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/22	08:30	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/22	08:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/19	22:00	GlobeNewswire Inc.	Oruka Therapeutics to Present at Piper Sandler’s 36th Annual Healthcare Conference	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/19	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/15	09:38	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/15	07:49	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/15	07:20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/15	06:56	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/15	02:04	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/14	23:56	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/14	20:37	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/14	06:25	GlobeNewswire Inc.	Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/14	06:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/11/04	21:00	GlobeNewswire Inc.	Oruka Therapeutics to Present at Multiple November Investor Conferences	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/10/23	05:15	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/10/19	05:11	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/10/05	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/09/25	20:08	GlobeNewswire Inc.	Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/09/14	05:57	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/09/14	05:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/09/14	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/09/12	20:05	GlobeNewswire Inc.	Oruka Therapeutics Announces $200 Million Private Placement	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/09/12	20:00	GlobeNewswire Inc.	Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/09/07	06:08	Edgar (US Regulatory)	Form SC 13D - General Statement of Acquisition of Beneficial Ownership	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/09/07	06:07	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ORKA	Oruka Therapeutics Inc
2024/09/07	06:07	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ORKA	Oruka Therapeutics Inc